Chris Andersen is an Intensive Care Staff Specialist at Royal North Shore Hospital and a clinical researcher with the Kirby Institute and the George Institute for Global Health. His research interests are in reducing heterogeneity in critical care syndromes such as hypoxic respiratory failure and sepsis and in the management of subarachnoid haemorrhage.
Adjunct Senior Lecturer
Dr Christopher Andersen
BSc (Hon1), BA, MBBS (Hon), MClinTRes, PhD, FCICM
Publications
Journal articles
Soares J; Leung C; Campbell V; Van Der Vegt A; Malycha J; Andersen C, 2024, 'Intensive care unit admission criteria: a scoping review', Journal of the Intensive Care Society, 25, pp. 296 - 307, http://dx.doi.org/10.1177/17511437241246901
2024
Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC, 2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-61729-5
2024
Andersen CR; Presseau J; Shea B; Marti ML; McCoy M; Fernie G; McIntyre L; Delaney A; Chassé M; Saigle V; Marshall S; Fergusson DA; Graham I; Brehaut J; Turgeon AF; Lauzier F; Tugwell P; Zha X; Talbot P; Muscedere J; Marshall JC; Thavorn K; Griesdale D; English SW; Lucas B, 2024, 'What to Measure in Aneurysmal Subarachnoid Haemorrhage Research—An International Delphi Survey', Translational Stroke Research, http://dx.doi.org/10.1007/s12975-024-01271-8
2024
Venkatesh K; Glenn H; Delaney A; Andersen CR; Sasson SC, 2023, 'Fire in the belly: A scoping review of the immunopathological mechanisms of acute pancreatitis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1077414
2023
Barreto SG; Kaambwa B; Venkatesh K; Sasson SC; Andersen C; Delaney A; Bihari S; Pilcher D, 2023, 'Mortality and costs related to severe acute pancreatitis in the intensive care units of Australia and New Zealand (ANZ), 2003–2020', Pancreatology, 23, pp. 341 - 349, http://dx.doi.org/10.1016/j.pan.2023.04.006
2023
Galea I; Bandyopadhyay S; Bulters D; Humar R; Hugelshofer M; Schaer DJ; Abdulazim A; Alalade AF; Alexander SA; Amaro S; Amin-Hanjani S; Andersen CR; Anderson C; Anstey MH; Balla J; Bankole NDA; Bellapart J; Bhagat H; Blackburn SL; Brechmann M; Buehler PW; Burkhardt JK; Chen Y; Cohen J; Cooper PD; Coulthard LG; Cuadrado-Godia E; Dalton J; Delaney A; Doré S; Downer J; Dye J; Fernandez-Perez I; Flower O; Fülesdi B; Gaastra B; Gaberel T; Galea J; Gankpe GF; Garland P; Gentinetta T; Gram M; Graversen JH; Grover PJ; Guisado-Alonso D; Hasan D; Helmy A; Höhne J; Charlotte Hostettler I; Hrishi AP; Iihara K; Irwin DC; Jangra K; Jiménez-O'shanahan A; Keep RF; Koch M; Korja M; Kumar M; Llull L; Loan JJM; Lopez-Gonzalez M; Loch MacDonald R; Mahajan S; Martí-Fàbregas J; Medina-Suárez J; Moestrup S; More J; Morgan E; Muthuchellappan R; Nyquist P; Sosa Pérez C; Pillai P; Plesnila N; Javier Provencio J; Raith E; Ramos-Pachón A; Raymond SB; Regli L; Ruigrok YM; Saharan P; Samaniego EA; Schubert GA; Seppelt I; Sriganesh K; Suarez JI; Taylor J; Terpolilli NA; Testai FD; Tolosano E; Toma AK; On Tsang AC; Udy AA; Vallelian F; Vargas-Caballero M; Vercellotti GM; Vergouwen MDI; Waak M; Warming H; Whitfield PC; Kwok-Chu Wong G, 2023, 'Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation', Stroke, 54, pp. 1930 - 1942, http://dx.doi.org/10.1161/STROKEAHA.123.040205
2023
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907
2023
Andersen CR; English SW; Delaney A, 2022, 'Made to measure—Selecting outcomes in aneurysmal subarachnoid hemorrhage research', Frontiers in Neurology, 13, http://dx.doi.org/10.3389/fneur.2022.1000454
2022
Hastak PS; Andersen CR; Kelleher AD; Sasson SC, 2022, 'Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.983550
2022
Andersen CR; Presseau J; Saigle V; Fitzgerald E; Lamanna M; Talbot P; Delaney A; English SW, 2022, 'Prioritizing outcome measures after aneurysmal subarachnoid hemorrhage: A q-sort survey of patients, health care providers and researchers', Frontiers in Neurology, 13, http://dx.doi.org/10.3389/fneur.2022.1068499
2022
Quinn L; Tian DH; Fitzgerald E; Flower O; Andersen C; Hammond N; Davidson K; Delaney A, 2020, 'The association between hyponatraemia and long-term functional outcome in patients with aneurysmal subarachnoid haemorrhage: A single centre prospective cohort study', Journal of Clinical Neuroscience, 78, pp. 353 - 359, http://dx.doi.org/10.1016/j.jocn.2020.06.003
2020
Andersen CR; Fitzgerald E; Delaney A; Finfer S, 2019, 'A Systematic Review of Outcome Measures Employed in Aneurysmal Subarachnoid Hemorrhage (aSAH) Clinical Research', Neurocritical Care, 30, pp. 534 - 541, http://dx.doi.org/10.1007/s12028-018-0566-0
2019
Andersen CR; Presseau J; Saigle V; Etminan N; Vergouwen MDI; English SW, 2019, 'Core outcomes for subarachnoid haemorrhage', The Lancet Neurology, 18, pp. 1075 - 1076, http://dx.doi.org/10.1016/S1474-4422(19)30412-0
2019
Munier CM; Andersen CR; Kelleher , 2011, 'HIV vaccines: Progress to date', Drugs, 71, pp. 387 - 414, http://adisonline.com/drugs/Abstract/2011/71040/HIV_Vaccines__Progress_to_Date.2.aspx
2011
Preprints
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358
2023
Grants
Medical Research Future Fund, Clinical Trials Activity 2022 CI $AUD 1 999 834, FLASH Trial - Fludrocortisone in ICU patients with aneurysmal Subarachnoid Haemorrhage
Canadian Institute of Health Research Spring 2024 Grant Round Co Principal Investigator $CAD726 752. Establishing an International Core Outcome Set in SAH
UNSW Triple I Grant 2023, Co-Investigator $AUD 75 000 Immune mechanisms of direct and indirect lung injury
UNSW Resource Infrastructure Scheme (RIS) 2023 Co-investigator $AUD 300 000 BD Rhapsody Single Cell Analysis System
NSW Health Statewide Biobank 2022 Biospecimens Collection Grant Round 3 Principal Investigator $AUD50 000 Critical Illness, Inflammation and Immunology Biobank (CI3 Biobank)
NSW Health Statewide Biobank 2022 Biospecimens Collection Grant Round 3 Co Investigator $AUD50 000 Australian Brain Injury Biobank
The Ottawa Hospital Academic Medical Organization (TOHAMO) 2021, Innovation Fund Grant Principal Investigator $CAD 100 000 Establishing an International Core Outcome Set in SAH
Canadian Institute of Health Research 2020, Strategy for Patient-Oriented Research (SPOR) Co Investigator $CAD100 000, Establishing an International Core Outcome Set in SAH
Medical Research Future Fund 2019 International Clinical Trial Collaborators Program Co Investigator $AUD 902 752 SAHaRA Trial - Haemoglobin Thresholds in Subarachnoid Haemorrhage
Oxford University Medical Sciences Division 2019 Pump Priming Grant - Co-Principal Investigator £GBP 9469 ImmuneCAP - Immune responses in Community Acquired Pneumonia
Intensive Care Foundation (Australia) 2019 Project Grant - Principal Investigator $AUD 24 500 Tissue resident memory cells in community acquired pneumonia